Home » China Private Equity »


|| Chinese investors of XIO Group acquired medical firm Lumenis for $500 million

xio-lmns.jpgChinese investment firm XIO Group has acquired Israeli medical firm Lumenis for $510 million.

NASDAQ-listed Lumenis provides energy-based, minimally invasive clinical solutions for the surgical, ophthalmology and aesthetic markets. (Its locations include Yokneam, Israel, where surgical and aesthetic products are manufactured, and Salt Lake City, Utah, where ophthalmic products are manufactured). XIO Group is a Hong Kong based alternative investments firm with over $ 3 billion in capital.

XIO Group is listed in the Chinese Private Equity and Venture Capital Directory with the code XJU44

More details follows



Previous Post: Chinese investors of Hua Capital and consortium acquired OmniVision for $1.9 billion
Next Post: Chinese firm invested $12 million in UK oil and gas technology firm Plexus

More from China Private Equity ...


  Chinese private equity firm and consortium invested $75 million in US firm Nobell Foods

  Chinese firm CreditEase and consortium invested $250 million in US firm Pipe

  Chinese PE firm TMCP invested $2.4 million in US firm RNAimmune

  Chinese investors of Ping An acquired stake in Israel MeMed for $70 million

  Chinese private equity firm to invest $270 million in blockchain firm tZero

  China Gaw Capital acquired 50% stake in Spanish hotel chain valued at $145 million

  Chinese firm Beijing Bytedance acquired Musical.ly for $800 million

  Chinese investors of AGIC Capital acquired South Carolina Ritedose for $600 million

  Chinese firm acquired US car assembly plant AM General for $110 million

  Chinese HNA Group acquired stake in Swiss firm Dufry





| About Us

Rubenstein
SinaBeat.com provides insight, analysis and research on private investors from China since 2012.

We cover Private Equity, Venture Capital, Real Estate and Institutional Investors from China, Hong Kong and Macau.

Our Chinese Investors Directory can be used as a reliable source on information about investors from China.



|Subscribe to mailing list

Enter your email address:



Careers  |  Sponsorship |  Sitemap |  Terms  |  Privacy Policy

Copyright 2007 - 2022     SinaBeat.com

Follow us: RSS  |   SinaBeat on Twitter  |   SinaBeat on Facebook  |   SinaBeat on LinkedIn